Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 8/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | DAGLA | Q9Y4D2 | 5/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18948470 | 1.00 | LMNA (0.37) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL24688358 | 1.00 | LMNA (0.37) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL19890352 | 1.00 | LMNA (0.37) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL21004269 | 1.00 | LMNA (0.37) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL26078434 | 0.98 | LMNA (0.36) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL19134116 | 0.98 | DNM1 (0.38) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL21715637 | 0.98 | OPRM1 (0.34) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL7524050 | 0.96 | DNM1 (0.34) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL26546032 | 0.92 | NR1I2 (0.41) | LMNAKDM4EUSP2ALOX15ALOX12 | |
| SCHEMBL23709479 | 0.91 | BDKRB2 (0.35) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11178871-B2 | Herbicidal pyrimidine compounds | BASF SE (DE) | 2021-11-23 | — | — | US | disclosed |
| US-20190159453-A1 | HERBICIDAL PYRIMIDINE COMPOUNDS | BASF SE (DE) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11178871-B2 | Herbicidal pyrimidine compounds | DPYD, TYMP, TYMS | LMNA 4460/4885KDM4E 2747/4885USP2 3302/4885 |
| US-20190159453-A1 | HERBICIDAL PYRIMIDINE COMPOUNDS | DPYD, TYMP, TYMS | LMNA 4460/4885KDM4E 2747/4885USP2 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.